Regional intestinal drug permeation: biopharmaceutics and drug development.

  • Hans Lennernaes
  • Published 2014 in
    European journal of pharmaceutical sciences…

Abstract

Over the last 25 years, profound changes have been seen in both the development and regulation of pharmaceutical dosage forms, due primarily to the extensive use of the biopharmaceutical classification system (BCS) in both academia and industry. The BCS and the FDA scale-up and post-approval change guidelines were both developed during the 1990s and both… (More)
DOI: 10.1016/j.ejps.2013.08.025

Topics

  • Presentations referencing similar topics